![Iain W. Duncan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Iain W. Duncan
Keine laufenden Positionen mehr
Profil
Iain W.
Duncan was the founder of Corus Pharma, Inc. founded in 2001, where he held the title of Vice President-Operations from 2001 to 2008.
He was a Principal at PathoGenesis Corp and Lyondell Chemical Co. He was also a Senior Vice President-Operations at Horizon Therapeutics, Inc. from 2009 to 2010.
Mr. Duncan received an undergraduate degree from Trent University.
Ehemalige bekannte Positionen von Iain W. Duncan
| Unternehmen | Position | Ende |
|---|---|---|
Horizon Therapeutics, Inc.
 Horizon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops prescription drugs for mild to moderate pain relief | Geschäftsführer | 05.04.2010 |
Corus Pharma, Inc.
 Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat needs in the infectious diseases and respiratory areas | Gründer | 04.12.2008 |
Lyondell Chemical Co.
 Lyondell Chemical Co. Finance/Rental/LeasingFinance Functions as a financing subsidiary/special purpose entity | Corporate Officer/Principal | - |
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Develops and markets innovative treatments for chronic infectious diseases | Corporate Officer/Principal | - |
Ausbildung von Iain W. Duncan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
11
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Develops and markets innovative treatments for chronic infectious diseases | Health Technology |
Lyondell Chemical Co.
Lyondell Chemical Co. Finance/Rental/LeasingFinance Functions as a financing subsidiary/special purpose entity | Finance |
Corus Pharma, Inc.
Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat needs in the infectious diseases and respiratory areas | Health Technology |
Trent University
 Trent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Horizon Therapeutics, Inc.
Horizon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops prescription drugs for mild to moderate pain relief | Health Technology |
